Schrodinger, Inc. (SDGR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US80810D1037
Schrodinger, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 255.87 m USD |
| Gross profit | 142.61 m USD |
| Operating income | -166.90 m USD |
| EBIT | -102.33 m USD |
| Net income | -103.27 m USD |
| Diluted EPS – continuing operations | -1.41 USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Schrodinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
More stocks
- MIXUE Group (MXUBY)
- China Wafer Level Csp Co Ltd (603005.SS)
- Brookfield Business Corp (BBUC)
- ZhongAn Online P & C Insurance Co Ltd (6060.HK)
- DoubleVerify Holdings, Inc. (DV)
- Henan Liliang Diamond Co. Ltd. (301071.SZ)
- NEOGENOMICS INC (NEO)
- Companhiade Eletricidade do Estado da Bahia - COELBA (CEEB3.SA)
- Custom Truck One Source, Inc. (CTOS)
- Law Debenture Corporation PLC (LWDB.L)
- Chenbro Micom Co Ltd (8210.TW)
- L&F Co. Ltd (066970.KS)
Not investment advice. All data without warranty, price as of 04.11.2026. Details in the risk notice.